Physical capacity and risk for long-term sickness absence: a prospective cohort study among 8664 female health care workers

Journal of Occupational and Environmental Medicine
Charlotte Diana Nørregaard RasmussenAndreas Holtermann

Abstract

To assess the prospective associations between self-reported physical capacity and risk of long-term sickness absence among female health care workers. Female health care workers answered a questionnaire about physical capacity and were followed in a national register of sickness absence lasting for two or more consecutive weeks during 1-year follow-up. Using Cox regression hazard ratio analyses adjusted for age, smoking, body mass index, physical workload, job seniority, psychosocial work conditions, and previous sickness absence, we modeled risk estimates for sickness absence from low and medium physical capacity. Low and medium aerobic fitness, low muscle strength, low flexibility, and low overall physical capacity significantly increased the risk for sickness absence with 20% to 34% compared with health care workers with high capacity. Low physical capacity increases the risk of long-term sickness absence among female health care workers.

References

Jan 1, 1992·European Journal of Applied Physiology and Occupational Physiology·P EraE Heikkinen
Jan 1, 1987·European Journal of Applied Physiology and Occupational Physiology·C H NygårdJ Ilmarinen
Jul 1, 1994·American Journal of Industrial Medicine·S J LondonJ M Peters
Jan 1, 1995·European Journal of Applied Physiology and Occupational Physiology·M TorgénA Kilbom
Mar 23, 1999·American Journal of Industrial Medicine·B A EvanoffL D Wolf
May 22, 2002·Scandinavian Journal of Work, Environment & Health·Karin I ProperWillem van Mechelen
May 22, 2002·Scandinavian Journal of Work, Environment & Health·Eija NurminenTimo Aro
Jun 28, 2002·Journal of Occupational and Environmental Medicine·Willy Eriksen, Dag Bruusgaard
Mar 12, 2003·Clinical Journal of Sport Medicine : Official Journal of the Canadian Academy of Sport Medicine·Karin I ProperWillem van Mechelen
Mar 18, 2004·Journal of Epidemiology and Community Health·J VahteraM Kivimäki
Apr 9, 2005·BMJ : British Medical Journal·Max HendersonKevin Holland Elliott
Sep 27, 2005·Scandinavian Journal of Medicine & Science in Sports·L MikkelssonH Nupponen
Apr 28, 2006·Occupational Medicine·Ludovic G P M van AmelsvoortIjmert Kant
Jun 15, 2007·Perceptual and Motor Skills·Jesper StrøyerBente Schibye
Jan 15, 2008·Journal of Epidemiology and Community Health·Karl Bang ChristensenMika Kivimäki
Feb 26, 2008·Occupational Medicine·Heikki KyröläinenArja Häkkinen
Dec 8, 2009·Scandinavian Journal of Work, Environment & Health·Andreas HoltermannKaren Søgaard
Jan 5, 2011·Scandinavian Journal of Public Health·Jan Hyld PejtersenJakob Bue Bjorner
Apr 5, 2011·British Journal of Sports Medicine·A HoltermannG Sjøgaard
Oct 12, 2011·BMC Public Health·Marie Birk JørgensenKaren Søgaard
Nov 1, 1990·American Journal of Health Promotion : AJHP·L A TuckerG M Friedman
Mar 7, 2012·The Annals of Occupational Hygiene·Elin KoppelaarAlex Burdorf
Jun 21, 2012·Scandinavian Journal of Work, Environment & Health·Lars L AndersenAndreas Holtermann
Mar 29, 2014·Sports Medicine·Neha Mukesh Amlani, Fehmidah Munir

❮ Previous
Next ❯

Citations

Feb 12, 2019·Annals of Internal Medicine·Pontus HenrikssonFrancisco B Ortega
Nov 18, 2018·International Archives of Occupational and Environmental Health·Suzanne L MerkusKaj Bo Veiersted
Nov 3, 2017·International Journal of Nursing Practice·Hana BrborovićOgnjen Brborović
Nov 19, 2021·International Journal of Occupational Safety and Ergonomics : JOSE·Charlotte WåhlinEmma Nilsing Strid

❮ Previous
Next ❯

Related Concepts

Trending Feeds

COVID-19

Coronaviruses encompass a large family of viruses that cause the common cold as well as more serious diseases, such as the ongoing outbreak of coronavirus disease 2019 (COVID-19; formally known as 2019-nCoV). Coronaviruses can spread from animals to humans; symptoms include fever, cough, shortness of breath, and breathing difficulties; in more severe cases, infection can lead to death. This feed covers recent research on COVID-19.

Blastomycosis

Blastomycosis fungal infections spread through inhaling Blastomyces dermatitidis spores. Discover the latest research on blastomycosis fungal infections here.

Nuclear Pore Complex in ALS/FTD

Alterations in nucleocytoplasmic transport, controlled by the nuclear pore complex, may be involved in the pathomechanism underlying multiple neurodegenerative diseases including Amyotrophic Lateral Sclerosis and Frontotemporal Dementia. Here is the latest research on the nuclear pore complex in ALS and FTD.

Applications of Molecular Barcoding

The concept of molecular barcoding is that each original DNA or RNA molecule is attached to a unique sequence barcode. Sequence reads having different barcodes represent different original molecules, while sequence reads having the same barcode are results of PCR duplication from one original molecule. Discover the latest research on molecular barcoding here.

Chronic Fatigue Syndrome

Chronic fatigue syndrome is a disease characterized by unexplained disabling fatigue; the pathology of which is incompletely understood. Discover the latest research on chronic fatigue syndrome here.

Evolution of Pluripotency

Pluripotency refers to the ability of a cell to develop into three primary germ cell layers of the embryo. This feed focuses on the mechanisms that underlie the evolution of pluripotency. Here is the latest research.

Position Effect Variegation

Position Effect Variagation occurs when a gene is inactivated due to its positioning near heterochromatic regions within a chromosome. Discover the latest research on Position Effect Variagation here.

STING Receptor Agonists

Stimulator of IFN genes (STING) are a group of transmembrane proteins that are involved in the induction of type I interferon that is important in the innate immune response. The stimulation of STING has been an active area of research in the treatment of cancer and infectious diseases. Here is the latest research on STING receptor agonists.

Microbicide

Microbicides are products that can be applied to vaginal or rectal mucosal surfaces with the goal of preventing, or at least significantly reducing, the transmission of sexually transmitted infections. Here is the latest research on microbicides.